Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 21 for “"Non-compartmental analysis"”.

  1. Statistical analysis of pharmacokinetic data : bioequivalence study

    … (PK) parameters as introduced in a Non-Compartmental Analysis (NCA) approach and Compartmental Models Analysis approach. Widely cited data sets from the published literature are used to illustrate these two approaches. They show the benefits of parameter estimation and subsequent …

    msu Repository record for Statistical analysis of pharmacokinetic data : bioequivalence study (opens in a new tab)

  2. Characterizing the transport and disposition of resveratrol and its metabolites in the presence of MRP2, BCRP and enterohepatic circulation inhibitors

    … R3G and R3S were monitored using LC-MS/MS. Non-compartmental analysis was performed to obtain pharmacokinetic parameters. We observed that the inhibition of efflux transporters had a greater impact on area under the curve (AUC) of R3S as compared to R3G and resveratrol. Resveratrol and R3G …

    temple Repository record for Characterizing the transport and disposition of resveratrol and its metabolites in the presence of MRP2, BCRP and enterohepatic circulation inhibitors (opens in a new tab)

  3. The Pharmacokinetics Of Enterohepatic Circulation

    … of the EHC process. The objective of the current analysis is to further develop our understanding of the application of modeling and simulation to drugs undergoing EHC. We propose a gallbladder-based model that provides a more physiological representation of the EHC process. The model was used in …

    umn Repository record for The Pharmacokinetics Of Enterohepatic Circulation (opens in a new tab)

  4. Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV

    … over a 24 hour-period for dolutegravir assays. Non-compartmental analysis was conducted and geometric mean ratios (GMRs), with 90% confidence intervals (CIs), were generated to compare dolutegravir pharmacokinetic parameters between the groups. Regression analyses to assess predictors of …

    cape-town Repository record for Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV (opens in a new tab)

  5. Pharmacokinetics and limited sampling strategies of mycophenolic acid in islet transplant recipients

    … pharmacokinetic parameters were determined by non-compartmental analysis. Multiple regression analysis was used to develop the LSSs, using all 16 patients’ profiles. The resulting equations were validated for their bias and precision using the jackknife method. There was large inter-patient …

    ubc Repository record for Pharmacokinetics and limited sampling strategies of mycophenolic acid in islet transplant recipients (opens in a new tab) Download PDF for Pharmacokinetics and limited sampling strategies of mycophenolic acid in islet transplant recipients (opens in a new tab)

  6. Sampling and pharmacokinetics of skin interstitial fluid for therapeutically monitored drugs

    … and their PK parameters were determined using non-compartmental analysis. Furthermore, steady-state concentrations were predicted from the single-dose study for blood and ISF. At equilibrium, ISF drug concentrations were higher (vancomycin and gentamicin) and more stable compared to blood …

    ubc Repository record for Sampling and pharmacokinetics of skin interstitial fluid for therapeutically monitored drugs (opens in a new tab) Download PDF for Sampling and pharmacokinetics of skin interstitial fluid for therapeutically monitored drugs (opens in a new tab)

  7. Oral cannabidiol administrations in horses: Pharmacokinetic modelling, behavioural observations and implications for medication control

    … group: 3 mg CBD/kg). For the pharmacokinetic analysis, blood and urine samples were taken daily during both study parts. After day 15 of the multiple dose study, additional samples were collected for two weeks to analyse the elimination phase. Concentrations of CBD, CBD metabolites and other …

    fu-berlin Repository record for Oral cannabidiol administrations in horses: Pharmacokinetic modelling, behavioural observations and implications for medication control (opens in a new tab)

  8. Pharmacokinetics of Inhaled Clofazimine in Mice

    … Inappropriate treatment implementation, patient non-compliance and extensive treatment regimen has led to increasing prevalence of multidrug resistant (MDR) and extremely drug resistant (XRD) Mycobacterial strains. Therefore, there is an urgent need for alternative TB treatments including the …

    creighton Repository record for Pharmacokinetics of Inhaled Clofazimine in Mice (opens in a new tab)

  9. IDENTIFICATION OF CLINICAL, LABORATORY AND GENETIC COVARIATES FOR PHARMACOKINETICS, EFFICACY AND TOXICITY OF SORAFENIB IN PATIENTS WITH SOLID TUMORS

    … II clinical trials at National Cancer Institute. Non-compartmental analysis-general linear modeling (NCA-GLM), population pharmacokinetic analysis and several correlative studies were performed to characterize the sources of variability in pharmacokinetics and response. The role of prostate …

    vcu Repository record for IDENTIFICATION OF CLINICAL, LABORATORY AND GENETIC COVARIATES FOR PHARMACOKINETICS, EFFICACY AND TOXICITY OF SORAFENIB IN PATIENTS WITH SOLID TUMORS (opens in a new tab)

  10. Pharmacokinetics and cardiovascular effects of increasing doses of glycopyrrolate in New Zealand white rabbits

    … 30 minutes after administration of each dose. Analysis of plasma glycopyrrolate concentrations was performed using liquid chromatography-tandem mass spectrometry. In phase 1, non-compartmental analysis showed fast clearance (113 ± 45.55 mL/kg/min), a relatively large volume of distribution …

    guelph Repository record for Pharmacokinetics and cardiovascular effects of increasing doses of glycopyrrolate in New Zealand white rabbits (opens in a new tab)

  11. Therapeutic Drug Monitoring of Factor VIII Prophylaxis Using Its Plasma Coagulant Activity and Global Hemostasis Biomarkers: A Pharmacokinetic/Pharmacodynamic Pilot Study

    … biomarkers in severe hemophilia. Methods: Nine non-bleeding severe hemophiliacs (plasma FVIII:C <1 IU dL-1) with variant bleeding tendency (5 frequent bleeders and 4 infrequent bleeders) were infused with a recombinant factor FVIII (rFVIII) prophylactic dose (mean = 32.1 international units per …

    vcu Repository record for Therapeutic Drug Monitoring of Factor VIII Prophylaxis Using Its Plasma Coagulant Activity and Global Hemostasis Biomarkers: A Pharmacokinetic/Pharmacodynamic Pilot Study (opens in a new tab)

  12. REPURPOSING DRUGS AND DESIGNS FOR MYCOBACTERIAL INFECTIONS

    … 16-hour sputum samples for quantitative analysis to determine time to positivity and CFU/mL and underwent sparse PK sampling. Results: There was detectable EBA using liquid and solid media techniques and these measurements largely aligned at each time point. A linear model on the …

    jhu Repository record for REPURPOSING DRUGS AND DESIGNS FOR MYCOBACTERIAL INFECTIONS (opens in a new tab) Embargoed until 2027-05-01

  13. Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance

    … drugs. Linezolid is a repurposed oxazolidinone antimicrobial with bactericidal activity against M. tuberculosis. Guidelines recommend linezolid as a preferred antituberculosis agent for RR-TB, and it is widely used in national programmes. The major drawback of linezolid is dose-related …

    cape-town Repository record for Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance (opens in a new tab)

  14. Comparison of commercial itraconazole to aerosolized nanoparticle itraconazole in a murine model for the prevention of invasive pulmonary aspergillosis (IPA)

    … Pharmacokinetic parameters were determined using non-compartmental analysis. Statistical comparisons were conducted via one-way analysis of variance (ANOVA) and Tukey-Kramer. Statistical significance was set at p < 0.05. RESULTS: The overall starting inoculum (log₁₀ mean ± SEM) of Aspergillus …

    texas Repository record for Comparison of commercial itraconazole to aerosolized nanoparticle itraconazole in a murine model for the prevention of invasive pulmonary aspergillosis (IPA) (opens in a new tab) Restricted access

  15. Pharmakokinetik und Metabolismus von delta9-Tetrahydrocannabinolsäure A im Menschen

    … Analyse gemäß den Prinzipien der „compartmental“ und der „non-compartmental analysis“, mit der erstmals grundlegende pharmakokinetische Parameter der THCA (AUC, Clearance, Verteilungsvolumina, Halbwertzeiten sowie Makro- und Mikrokonstanten des Kompartimentmodells) bestimmt wurden. …

    freiburg-diss Repository record for Pharmakokinetik und Metabolismus von delta9-Tetrahydrocannabinolsäure A im Menschen (opens in a new tab)

  16. Discovery of Quinic Acid Derivatives as Oral Anti-inflammatory Agents

    … determined from concentration - time profiles by non-compartmental analysis. Bacterial stability study was conducted in cultured bacterial gluconobacter oxydans. Plasma protein binding and metabolic stability were determined using equilibrium dialysis and rat liver microsomes respectively. …

    tenn-hsc Repository record for Discovery of Quinic Acid Derivatives as Oral Anti-inflammatory Agents (opens in a new tab)

  17. Innovative techniques for selecting the dose of antibiotics in empiric therapy - focus on beta-lactams and cystic fibrosis patients

    … of various body size. General methods: Drug analysis in plasma and urine was performed by HPLC or LC-MS/MS in a single laboratory, at the IBMP. Drug analysis was not done by the author of this thesis. We used non-compartmental analysis and parametric population PK analysis for all studies. We …

    wurz-thes Repository record for Innovative techniques for selecting the dose of antibiotics in empiric therapy - focus on beta-lactams and cystic fibrosis patients (opens in a new tab)

  18. Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models

    … and IFN? were determined by LC-MSMS and ELISA analysis respectively. The data were initially analysed by non-compartmental analysis to determine the pharmacokinetics of resiquimod. Statistical and power analysis were then applied to determine the reproducibility of the model between study days …

    strathclyde Repository record for Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models (opens in a new tab)

  19. Clinical Pharmacology of First- and Second-Line Treatments of Convulsive Status Epilepticus

    … guideline recommendations. Following an interim analysis, additional training was provided to study teams at participating sites designed to increase the awareness of appropriate benzodiazepine dosing. However, these educational efforts did not improve the pattern of underdosing overall or …

    umn Repository record for Clinical Pharmacology of First- and Second-Line Treatments of Convulsive Status Epilepticus (opens in a new tab)

  20. Development, characterization and application of biocompatible co-polymers with cyclodextrins as carriers for nasal drug delivery in neurodegenerative diseases: in vitro, ex vivo and in vivo evaluation

    … has gained increasing attention as a non-invasive approach to overcoming these limitations. The direct anatomical connection between the olfactory epithelium and the CNS enables drug transport to the brain, making the nasal route particularly advantageous for molecules with poor BBB …

    greece Repository record for Development, characterization and application of biocompatible co-polymers with cyclodextrins as carriers for nasal drug delivery in neurodegenerative diseases: in vitro, ex vivo and in vivo evaluation (opens in a new tab)

Page 1 of 2